SCP
CVS icon

Shorepoint Capital Partners’s CVS Health CVS Stock Holding History

Shorepoint Capital Partners’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$4.7M Buy
+62,292
New +$4.27M 0.93% 42
2025
Q1 		$4.39M Sell
64,744
-2,207
-3% -$132K 0.99% 40
2024
Q4 		$3.01M Sell
66,951
-3,443
-5% -$193K 0.69% 54
2024
Q3 		$4.43M Sell
70,394
-1,710
-2% -$99.8K 1.01% 39
2024
Q2 		$4.26M Buy
72,104
+1,941
+3% +$121K 1% 39
2024
Q1 		$5.6M Buy
70,163
+1,161
+2% +$88.7K 1.37% 28
2023
Q4 		$5.45M Buy
+69,002
New +$4.91M 1.46% 21
2023
Q3 		– Sell
-63,987
Closed -$4.53M – 28
2023
Q2 		$4.42M Buy
63,987
+7,086
+12% +$504K 1.25% 28
2023
Q1 		$4.23M Sell
56,901
-1,421
-2% -$119K 1.21% 30
2022
Q4 		$5.43M Sell
58,322
-3,501
-6% -$338K 1.51% 22
2022
Q3 		$5.9M Sell
61,823
-812
-1% -$80.4K 2.81% 7
2022
Q2 		$5.8M Sell
62,635
-5,131
-8% -$501K 2.45% 8
2022
Q1 		$6.86M Sell
67,766
-6,560
-9% -$689K 2.86% 6
2021
Q4 		$7.67M Sell
74,326
-4,092
-5% -$378K 3.11% 5
2021
Q3 		$6.66M Buy
+78,418
New +$6.57M 2.99% 5
2021
Q1 		$5.46M Sell
72,560
-314
-0.4% -$22.9K 2.92% 4
2020
Q4 		$4.98M Buy
72,874
+2,604
+4% +$169K 2.76% 7
2020
Q3 		$4.1M Buy
70,270
+4,459
+7% +$277K 2.55% 8
2020
Q2 		$4.28M Sell
65,811
-4,121
-6% -$260K 2.79% 5
2020
Q1 		$4.15M Sell
69,932
-2,926
-4% -$195K 3.33% 4
2019
Q4 		$5.41M Sell
72,858
-4,544
-6% -$319K 3.1% 3
2019
Q3 		$4.88M Buy
77,402
+407
+0.5% +$24.1K 2.88% 4
2019
Q2 		$4.2M Sell
76,995
-7,121
-8% -$383K 2.39% 8
2019
Q1 		$4.54M Buy
+84,116
New +$5.19M 2.57% 8

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Shorepoint Capital Partners's CVS Position: Q3 2025 in Review

Shorepoint Capital Partners opened a new position in CVS Health (CVS) in Q3 2025: 62,292 shares worth $4.7M. The stake represents 0.93% of the portfolio and ranks #42 among its holdings. This is a return to the name: Shorepoint Capital Partners previously reported a position in CVS as recently as Q1 2025.

Shorepoint Capital Partners first reported a position in CVS in Q1 2019 and has held it in 24 quarters since. The position peaked at $7.67M in Q4 2021. 1,834 funds tracked by Wall St. Rank hold CVS as of Q3 2025.

  • Shorepoint Capital Partners held 62,292 shares of CVS Health worth $4.7M as of Q3 2025.
  • CVS Health was a new Shorepoint Capital Partners position in Q3 2025.
  • CVS Health made up 0.93% of Shorepoint Capital Partners's portfolio in Q3 2025, its #42 holding.
  • Shorepoint Capital Partners first reported a position in CVS Health in Q1 2019 and has held it in 24 quarters since.
  • Shorepoint Capital Partners's CVS Health position peaked at $7.67M in Q4 2021.
  • 1,834 funds tracked by Wall St. Rank held CVS Health as of Q3 2025.

Based on Shorepoint Capital Partners's 13F filing for Q3 2025, filed 3 Oct 2025.